Form 8-K - Current report:
SEC Accession No. 0001193125-23-068392
Filing Date
2023-03-13
Accepted
2023-03-13 06:05:30
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d484658d8k.htm   iXBRL 8-K 23085
  Complete submission text file 0001193125-23-068392.txt   143620

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA meip-20230310.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20230310_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20230310_pre.xml EX-101.PRE 11266
6 EXTRACTED XBRL INSTANCE DOCUMENT d484658d8k_htm.xml XML 3342
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 23725562
SIC: 2834 Pharmaceutical Preparations